Literature DB >> 11574194

Worldwide guidelines for respiratory tract infections: community-acquired pneumonia.

K Dalhoff1.   

Abstract

The management of respiratory tract infections is a complex process. Concern over increasing levels of bacterial resistance and the inappropriate use of antibiotics has led to the development of clinical guidelines for the treatment of respiratory tract infections. Despite the development of these guidelines, a consensus on the optimal care for lower respiratory tract infections has not been attained. Guidelines for the management of community-acquired pneumonia (CAP) have been developed since the 1990s in the USA, Canada, and a number of European countries. Constant re-evaluation of guidelines for CAP is necessary to ensure that the recommendations that were made in the early 1990s still hold true in the new millennium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574194     DOI: 10.1016/s0924-8579(01)00405-8

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Hospital pharmacists' awareness of a new antibiotic guideline in the UK: implications for practice.

Authors:  Eleanor M Woodford; Keith A Wilson; John F Marriott
Journal:  Pharm World Sci       Date:  2005-06

2.  In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides.

Authors:  Darren Abbanat; Glenda Webb; Barbara Foleno; Y Li; Mark Macielag; Deborah Montenegro; Ellyn Wira; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Evaluation and significance of C-reactive protein in the clinical diagnosis of severe pneumonia.

Authors:  Jianjun Wu; Y U Jin; Hailong Li; Zhiping Xie; Jinsong Li; Yuanyun Ao; Zhaojun Duan
Journal:  Exp Ther Med       Date:  2015-05-12       Impact factor: 2.447

Review 4.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  [Community-acquired and nosocomial pneumonia].

Authors:  T Welte
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

6.  Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

Authors:  Beat Müller; Stephan Harbarth; Daiana Stolz; Roland Bingisser; Christian Mueller; Jörg Leuppi; Charly Nusbaumer; Michael Tamm; Mirjam Christ-Crain
Journal:  BMC Infect Dis       Date:  2007-03-02       Impact factor: 3.090

Review 7.  [Managing lower respiratory tract infections in immunocompetent patients. Definitions, epidemiology, and diagnostic features].

Authors:  F Philippart
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.